Researchers use human vaccine to cure prostate cancer in mice

University of Leeds researchers, funded by Cancer Research UK, have used a library of DNA to create a vaccine that could be used to treat cancer, according to a study published in Nature Medicine.

Before now, 'gene therapy' vaccines have often delivered just one gene to stimulate the immune system. It produces a protein, called an antigen, which activates the immune system to destroy .

It has been difficult to develop successful cancer vaccines because each has specific proteins and identifying the right antigens has been a huge challenge.

Scientists have also tried to boost the effectiveness of vaccines by using several genes to increase the chances of producing successful antigens. But a worry has always been that the immune system's response would be too strong for the body to handle.

But now researchers, working with the Mayo Clinic in Rochester, US, have solved this problem in experiments involving mice.

The team used doses of a vaccine made from a virus which contained a 'library' of DNA, containing multiple fragments of genes and therefore many possible antigens. This approach did not send the immune system into overdrive, which had been a concern. Instead the range of DNA meant the vaccine was able to target the tumour through many routes.

Importantly, the DNA library was harvested from the same organ as the tumour. This meant that the immune system 'self-selected' the cancer antigens to respond to and did not react against other healthy parts of the body. Also, the process of self-selection was triggered when the vaccine was injected into the , an approach to vaccination that is far more practical than injecting directly into tumours.

The researchers delivered a library of DNA taken from healthy in mice. When delivered in a virus, the vaccine successfully treated mice with .

University of Leeds' Professor Alan Melcher, co-author of the study, said: "This is the first time we've been able to use a whole library of DNA in a viral vaccine successfully.

"The biggest challenge in immunology is developing that can target the tumour without causing harm elsewhere.

"By using DNA from the same part of the body as the tumour, inserted into a virus, we may be able to solve that problem."

The vaccine was made by putting the DNA library inside a vesicular stomatitis virus (VSV), which stimulates an immune response that can then track down and kill cells.

Professor Peter Johnson, Cancer Research UK's chief clinician, said: "This is an interesting and significant study which could really broaden out the field of immunotherapy research.

"Although the vaccine didn't trigger the immune system to overreact and cause serious side effects in mice, it will need to be further developed and tested in humans before we can tell whether this technique could one day be used to treat cancer patients."

More information: Broad Antigenic Coverage Induced by Viral cDNA Library-based Vaccination Cures Established Tumors. Kottke et al. Nature Medicine. 19 June 2011. DOI:10.1038/nm.2390

Related Stories

Tattooing improves response to DNA vaccine

Feb 07, 2008

A tattoo can be more than just a fashion statement – it has potential medical value, according to an article published in the online open access journal, Genetic Vaccines and Therapy.

Prostate cancer: Watchful wait or vaccinate?

Feb 01, 2008

Researchers at the University of Southern California have developed a prostate cancer vaccine that prevented the development of cancer in 90 percent of young mice genetically predestined to develop the disease. In the February ...

A new cancer vaccine starves tumors of blood

May 24, 2010

A DNA-vaccine that restricts the supply of blood to tumours has been developed by scientists at the Swedish medical university Karolinska Institutet. The vaccine slows the growth of breast cancer tumours in mice.

Goodbye needle, hello smoothie (w/Video)

Mar 17, 2009

(PhysOrg.com) -- Instead of a dreaded injection with a needle, someday getting vaccinated against disease may be as pleasant as drinking a yogurt smoothie.

Recommended for you

A new way to prevent the spread of devastating diseases

5 hours ago

For decades, researchers have tried to develop broadly effective vaccines to prevent the spread of illnesses such as HIV, malaria, and tuberculosis. While limited progress has been made along these lines, ...

New molecule allows for increase in stem cell transplants

5 hours ago

Investigators from the Institute for Research in Immunology and Cancer (IRIC) at the Université de Montréal have just published, in the prestigious magazine Science, the announcement of the discovery of a new molecule, the fi ...

Team explores STXBP5 gene and its role in blood clotting

8 hours ago

Two independent groups of researchers led by Sidney (Wally) Whiteheart, PhD, of the University of Kentucky, and Charles Lowenstein, MD, of the University of Rochester, have published important studies exploring the role that ...

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

FroShow
not rated yet Jun 20, 2011
Millions of suffering male mice the world over squeaked out in joy at the news of this article.
blazingspark
5 / 5 (1) Jun 20, 2011
Research like this could be accelerated forward faster if bureaucratic red tape didn't get in the way..

There are plenty of cancer patients inches from death that would give an arm and a leg to try this experimental stuff and they don't even get to make a choice.
I don't agree with that. If I was really close to death I would want my life to at least help push forward science so someone else has a better chance of surviving what I couldn't.